CN1060076C

CN1060076C - Gucixiao pill for removing spur

Info

Publication number: CN1060076C
Application number: CN97108265A
Authority: CN
Inventors: 冯根源
Original assignee: Individual
Current assignee: Individual
Priority date: 1997-10-21
Filing date: 1997-10-21
Publication date: 2001-01-03
Anticipated expiration: 2017-10-21
Also published as: CN1214920A

Abstract

The present invention relates to a Chinese patent drug, namely Gucixiao pills, which is prepared by mixing and processing raw materials of Chinese angelica root, sanchi, prepared flowery knotweed root, clematis root, etc. according to a certain proportion. The drug has specific effect on curing hyperosteogeny disease of the human body.

Description

A kind of Chinese patent medicine and compound method thereof for the treatment of hyperosteogeny disease

The present invention relates to a kind of treatment human body hyperosteogeny disease Chinese patent medicine and compound method thereof.

Hyperosteogeny is a kind of common multiple disease, especially with cervical vertebra, lumbar vertebra sickness rate height.From clinical observation, general more than 50 years old person's sickness rate reach more than 60%, between twenty and fifty sickness rate also is about 30%, because being a kind of organic pathology, hyperosteogeny changes, can bring the chronic disease of a series of symptoms after ill, thereby be difficult to cure, and relapse rate is high.This disease still there are not effective method for treatment and specific medicament both at home and abroad at present.

The object of the present invention is to provide a kind of drug effect height, the course of treatment is short relatively, taking convenience, and no obvious toxic-side effects all adopts the Chinese patent medicine of the treatment hyperosteogeny disease that natural Chinese medicinal herb combines.

The object of the present invention is achieved like this, adopting Chinese herbal medicine such as Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Squama Manis, Radix Clematidis, Caulis Sargentodoxae, Carapax Trionycis, the Cortex Eucommiae, Olibanum, Radix Dipsaci, Radix Cynanchi Paniculati, Rhizoma Gastrodiae, Rhizoma Drynariae, Ramulus Uncariae Cum Uncis, Semen Persicae, Bombyx Batryticatus, Radix Polygoni Multiflori Preparata, Cornu Cervi Degelatinatum, Radix Notoginseng, Flos Carthami, Myrrha is raw material, formulated by a certain percentage after processing.Its configuration proportion is that per 1 material contains respectively 1 part in Radix Notoginseng, Flos Carthami, Olibanum, Myrrha, Squama Manis, Semen Persicae, 0.5 part of Rhizoma Chuanxiong, respectively 1.2 parts of Radix Angelicae Sinensis, Rhizoma Drynariae, Ramulus Uncariae Cum Uncis, respectively 1.5 parts of Radix Salviae Miltiorrhizae, Cornu Cervi Degelatinatum, the Cortex Eucommiae, Radix Dipsaci, Radix Cynanchi Paniculati, Rhizoma Gastrodiae, Bombyx Batryticatus, 2 parts of Radix Clematidis, respectively 3 parts of Caulis Sargentodoxae, Radix Polygoni Multiflori Preparata, Carapax Trionycis.

Concrete processing and preparation method:

With respectively 1 part in Radix Notoginseng, Flos Carthami, Olibanum, Myrrha, Squama Manis, Semen Persicae, 0.5 part of Rhizoma Chuanxiong, respectively 1.2 parts of Radix Angelicae Sinensis, Rhizoma Drynariae, Ramulus Uncariae Cum Uncis, respectively 1.5 parts of Radix Salviae Miltiorrhizae, Cornu Cervi Degelatinatum, the Cortex Eucommiae, Radix Dipsaci, Radix Cynanchi Paniculati, Rhizoma Gastrodiae, Bombyx Batryticatus, 2 parts of Radix Clematidis, section is concocted behind Caulis Sargentodoxae, Radix Polygoni Multiflori Preparata, each 3 parts of wash clean of Carapax Trionycis, pulverizes the back again and crosses the sieve mixing No. 5, and last water is general to be ball.

This Chinese patent medicine has the nourishing kidney bone strengthening, tonifying the blood and stretching the tendon, the blood stasis dispelling row stagnates, the effect of removing obstruction in the collateral to relieve pain, the headache that human cervical spine hypertrophy disease is caused, migraine, dizzy, visual disorder, tinnitus, mistake eye, cardiopalmus, five hearts are done to burn, Hong antiperspirant, hypertension, damping off, rear pillow part pain, neck shoulder back limb are ached diseases such as numbness and moving obstacle; The sore waist and aching in the waist and the back that the hyperosteogeny disease causes, stiff, sciatica, the numb flaccidity syndrome and arthralgia syndrome of lower limb swelling and pain, symptom such as waist and lower limb exercise are limited; The pathological changes curative effect the bests such as disease that also have thoracic vertebra and other position hyperosteogeny to cause.Some pathological changes disease that the neural blood vessel dysfunction is caused, also effective in cure as angioneurotic headache, apoplectic hemiplegia, neuralgia, vasculitis, damage, soft-tissue strain etc., diseases such as the wet muscle BI-syndrome involved the blood vessels resistance that causes of wind and cold, arthralgia there is certain therapeutical effect.

Make Chinese patent medicine of the present invention and have the raw material abundance, processing technique is simple, small investment, having conventional Chinese patent medicine process equipment condition can produce, and the pharmaceutical effectiveness scope is wide, adaptability is strong, except that the careful usefulness of anemia of pregnant woman, men and women, old and young all can use, and human body is not had obvious toxic-side effects, evident in efficacy, short-term effect and long-term effect exceed like product.At present, the checking of example surplus in the of existing 2000, effective percentage reaches more than 98%, and people surplus first follows the tracks of 280 to no case was recurrence so far, has thoroughly reached the purpose of diseases such as rehabilitation hyperosteogeny and neural blood vessel dysfunction.

Claims

1, a kind of Chinese patent medicine for the treatment of hyperosteogeny disease, it is characterized in that: by Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Radix Polygoni Multiflori Preparata, Cornu Cervi Degelatinatum, Radix Notoginseng, Flos Carthami, Olibanum, Myrrha, Squama Manis, Radix Clematidis, Caulis Sargentodoxae, Carapax Trionycis, the Cortex Eucommiae, Radix Dipsaci, Radix Cynanchi Paniculati, Rhizoma Gastrodiae, Rhizoma Drynariae, Ramulus Uncariae Cum Uncis, Semen Persicae, Bombyx Batryticatus is formed, its usage ratio: per 1 material contains Radix Notoginseng, Flos Carthami, Olibanum, Myrrha, Squama Manis, each 1 part in Semen Persicae, 0.5 part of Rhizoma Chuanxiong, Radix Angelicae Sinensis, Rhizoma Drynariae, each 1.2 parts of Ramulus Uncariae Cum Uncis, Radix Salviae Miltiorrhizae, Cornu Cervi Degelatinatum, the Cortex Eucommiae, Radix Dipsaci, Radix Cynanchi Paniculati, Rhizoma Gastrodiae, each 1.5 parts of Bombyx Batryticatus, 2 parts of Radix Clematidis, Radix Polygoni Multiflori Preparata, Caulis Sargentodoxae, each 3 parts of Carapax Trionycis.

2, a kind of compound method for the treatment of the hyperosteogeny disease Chinese patent medicine, it is characterized in that: with respectively 1 part in Radix Notoginseng, Flos Carthami, Olibanum, Myrrha, Squama Manis, Semen Persicae, 0.5 part of Rhizoma Chuanxiong, respectively 1.2 parts of Radix Angelicae Sinensis, Rhizoma Drynariae, Ramulus Uncariae Cum Uncis, respectively 1.5 parts of Radix Salviae Miltiorrhizae, Cornu Cervi Degelatinatum, the Cortex Eucommiae, Radix Dipsaci, Radix Cynanchi Paniculati, Rhizoma Gastrodiae, Bombyx Batryticatus, 2 parts of Radix Clematidis, section is concocted behind Caulis Sargentodoxae, Radix Polygoni Multiflori Preparata, each 3 parts of wash clean of Carapax Trionycis, pulverize the back and cross the sieve mixing No. 5, last water is general to be ball.